Document Detail


Gastric bypass for morbidly obese patients with established cardiac disease.
MedLine Citation:
PMID:  17059734     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Bariatric surgery has often been avoided in patients with known cardiac disease because of the risks inherent in this patient population. This study was done to evaluate both the risks and benefits of Roux-en-Y gastric bypass (RYGBP) in morbidly obese patients with established cardiac disease. METHODS: Data were analyzed to compare preoperative with postoperative co-morbid cardiac risk factors, peri-operative and postoperative complications, and change in body mass index (BMI) in 77 consecutive patients who had a preoperative diagnosis of cardiac disease and underwent RYGBP between March 1998 and January 31, 2006. Findings were compared to a concomitant control group without cardiac disease. RESULTS: The preoperative presence of cardiac disease was manifested primarily as coronary artery disease (CAD) (45 patients) or as congestive heart failure (CHF) (32 patients). Of the patients with CAD, 60% had diabetes, 91% had hypertension and 39% had hyperlipidemia. 58% had one or more prior invasive cardiac procedures. In the CHF group, 50% had diabetes, 71% had hypertension and 44% had hyperlipidemia. The average length of stay was 3.7 days for CAD patients and 3.3 days for CHF compared to 3.0 days for controls. All co-morbid conditions were improved, and no patient died from cardiac disease. However, one patient died as a complication of GI bleeding, one patient subsequently underwent revascularization and another underwent stenting. Other complications up to 5 years postoperatively were frequent but seldom life-threatening. CONCLUSION: RYGBP surgery in patients with existing cardiac disease appears to have acceptable risk and is effective in reducing the co-morbid conditions of diabetes, hypertension, hyperlipidemia, sleep apnea and arthritis, but longer term data are needed.
Authors:
Grady D Alsabrook; Hope R Goodman; J Wesley Alexander
Related Documents :
3400904 - Cardiac arrest associated with halothane anesthesia in a patient receiving theophylline.
6967274 - Lyme carditis: cardiac abnormalities of lyme disease.
7544684 - Effects of hypertonic saline dextran on the postoperative evolution of jehovah's witnes...
15051644 - Left cardiac sympathetic denervation in the management of high-risk patients affected b...
12137314 - Perception of ecological factors in asthmatic and coronary patients.
17205494 - The ulcerated leg severity assessment score for prediction of venous leg ulcer healing.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obesity surgery     Volume:  16     ISSN:  0960-8923     ISO Abbreviation:  Obes Surg     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-10-24     Completed Date:  2007-01-10     Revised Date:  2007-12-05    
Medline Journal Info:
Nlm Unique ID:  9106714     Medline TA:  Obes Surg     Country:  England    
Other Details:
Languages:  eng     Pagination:  1272-7     Citation Subset:  IM    
Affiliation:
The Center for Surgical Weight Loss, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45219, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comorbidity
Coronary Disease / epidemiology*
Diabetic Angiopathies / epidemiology
Female
Gastric Bypass*
Heart Failure / epidemiology*
Humans
Length of Stay
Male
Middle Aged
Obesity, Morbid / epidemiology*,  surgery
Risk Assessment
Risk Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Internal hernia after laparoscopic Roux-en-Y gastric bypass for morbid obesity.
Next Document:  Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentration...